MYTREXATE-7.5

MYTREXATE 7.5 contains Methotrexate 7.5 mg, a disease-modifying antirheumatic drug (DMARD) used for the treatment of rheumatoid arthritis, psoriasis, and certain types of cancer. It works by suppressing the immune system to reduce inflammation and slow down the abnormal growth of cells.

This mid-range dose is commonly prescribed when a patient’s condition requires more than a low dose but not as high as 10 mg, offering flexibility in dosage adjustments for long-term therapy.

Key Features:
✅ Contains Methotrexate IP 7.5 mg
✅ Ideal for autoimmune disease and cancer therapy
✅ Used in rheumatoid arthritis, psoriasis, and some cancers
✅ Weekly oral dose for convenient administration
✅ Helps reduce joint pain, swelling, and skin symptoms